May 2003
Volume 44, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2003
Efficiency and Security of Intravitreal Triamcinolone for the Treatment of Pars Planitis
Author Affiliations & Notes
  • A. Babayan Sosa
    Cornea, Hospital de Nuestra Sra. de la Luz, Mexico City, Mexico
  • A. Levine
    Retina, Hospital de Nuestra Sra. de la Luz, Mexico City, Mexico
  • S. Rojas
    Retina, Hospital de Nuestra Sra. de la Luz, Mexico City, Mexico
  • R. García
    Retina, Hospital de Nuestra Sra. de la Luz, Mexico City, Mexico
  • E. Lopez
    Uveitis, Hospital de Nuestra Sra. de la Luz, Mexico City, Mexico
Investigative Ophthalmology & Visual Science May 2003, Vol.44, 2411. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      A. Babayan Sosa, A. Levine, S. Rojas, R. García, E. Lopez; Efficiency and Security of Intravitreal Triamcinolone for the Treatment of Pars Planitis . Invest. Ophthalmol. Vis. Sci. 2003;44(13):2411.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Abstract: : Purpose: To determine the efficiency and security of intravitreal triamcinolone for the treatment of pars planitis. Material and Methods: We included patients with clinical diagnosis of pars planitis that agreed to participate in the study. Triamcinole (4 mg/0.1 ml) was injected into the vitreous chamber in the operating room. Follow up was made for three months where the inflammations signs, visual acuity, ocular tension and complications were recorded. Results: Four patients were included with a mean age of 11.7 years. Inflammation in the anterior chamber was controlled in the first two weeks after treatment, while the posterior chamber inflammation decreased between 1 and 2 months after treatment . Two patients had ocular hipertension, one requiring surgery for its control. Conclusion: Intravitreal triamcinolone may be effective to control inflammation in patients with pars planitis, but there is a high risk for ocular hipertension.

Keywords: inflammation • corticosteroids • intraocular pressure 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×